查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586367

数位治疗市场、规模、占有率、趋势、行业分析报告：按收入模式、按应用、按最终用户、按地区 - 市场预测，2024-2032

Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model, Application, End Users, and Region - Market Forecast, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，数位治疗市场预计将达到 706.3 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

数位治疗市场的成长是由全球网路存取不断增加所推动的，不仅在已开发国家，而且在新兴市场也是如此。例如，根据《我们的数据世界》的统计，2000年，亚洲有7%的人口可以上网，而非洲只有3%。 2016年，网路接取人口比例大幅提升，韩国、日本91%的人口接取互联网，丹麦、挪威97%的人口接取网路。 6年后，也就是2022年，非洲主要地区有81%的人口将连上网路。

政府对整个生态系统进行数位化的举措和激励措施预计将在预测期内推动数位治疗市场的发展。增加政府对医疗保健行业的资助以及引入医疗保健行业数位化计划预计将在研究期间推动数位治疗市场的发展。例如，2023 年 8 月，印度政府在 Ayushman Bharat 数位使命 (ABDM) 下推出了数位健康激励计画 (DHIS)，以鼓励数位健康、实验室和健康科技公司的采用。数位健康奖励计画为新的健康科技新创公司提供高达 4 兆印度卢比的诱因。

数位治疗服务的主要消费者是僱主和病人。领先的公司开始在其员工套餐中添加治疗服务，提供生活方式管理、忧郁症和高血压相关服务。患有糖尿病、心血管疾病等慢性疾病的患者可以使用该服务进行日常咨询。

数位治疗市场报告亮点

收入模型分析预测，订阅细分市场将在全球市场显着成长。这种成长归因于与基于订阅的收入模式相关的主要优势。

最终用户分析预测，随着全球主要公司推出数位治疗套餐服务，僱主细分市场将在 2024 年至 2032 年期间主导市场。

由于拥有网路存取和先进数位化的人口比例很高，到 2023 年，北美将主导数位治疗市场。

由于医疗保健产业的监管支持和数位化举措，印度的数位治疗市场预计将大幅成长。

主要市场参与者包括Proteus Digital Health, Inc.、Fitbit, Inc.、Pear Therapeutics, Inc.、Kaia Health、Happify, Inc.、Medtronic Plc.、Omada Health, Inc.、Livongo Health, Inc.、 Voluntis Inc.、Resmed, Inc.、Welldoc, Inc.、2Morrow Inc.、Canary Health 和 Mindable Health GmbH。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第 4 章全球数位治疗市场洞察

  • 市场快照
  • 数位治疗市场动态
    • 促进因素和机会
      • 服务导向的软体的进步推动市场成长
      • 每日上网时间的增加正在推动市场规模的扩大
    • 阻碍因素和课题
      • 缺乏资本投资
  • PESTEL 分析
  • 数位治疗市场的趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第 5 章全球数位治疗市场：依收入模式划分

  • 主要发现
  • 简介
  • 订阅
  • 以价值为基础
  • 一次购买

第 6 章全球数位治疗市场：依应用划分

  • 主要发现
  • 简介
  • 糖尿病
  • 肥胖
  • 脑血管疾病（CVD）
  • 中枢神经系统疾病
  • 呼吸系统疾病
  • 禁止吸烟
  • 生活方式管理
  • 为了预防
  • 其他

第 7 章全球数位治疗市场：依最终使用者划分

  • 主要发现
  • 简介
  • 病人
  • 提供者
  • 付款人
  • 僱主
  • 其他

第 8 章全球数位治疗市场：按地区

  • 主要发现
  • 简介
    • 数位治疗市场评估：按地区划分，2019-2032 年
  • 北美
    • 北美：依收入模式划分，2019-2032 年
    • 北美：依申请划分，2019-2032 年
    • 北美：依最终使用者划分，2019-2032 年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依收入模式划分，2019-2032 年
    • 欧洲：依申请划分，2019-2032 年
    • 欧洲：依最终使用者划分，2019-2032 年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 亚太地区：依收入模式划分，2019-2032 年
    • 亚太地区：依应用程式划分，2019-2032 年
    • 亚太地区：依最终使用者划分，2019-2032 年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东/非洲
    • 中东和非洲：依收入模式划分，2019-2032 年
    • 中东与非洲：依申请划分，2019-2032 年
    • 中东和非洲：按最终用户划分，2019-2032 年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东/非洲
  • 拉丁美洲
    • 拉丁美洲：依所得模式划分，2019-2032 年
    • 拉丁美洲：依申请划分，2019-2032 年
    • 拉丁美洲：依最终使用者划分，2019-2032 年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Proteus Digital Health, Inc.
  • Fitbit Inc.
  • Pear Therapeutics, Inc.
  • Kaia Health
  • Happify, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Livongo Health, Inc.
  • Voluntis, Inc.
  • Resmed, Inc.
  • Welldoc, Inc.
  • 2Morrow Inc.
  • Canary Health
  • Mindable Health GmbH.
Product Code: PM1908

The digital therapeutics market size is expected to reach USD 70.63 billion by 2032, according to a new study by Polaris Market Research. The report "Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital therapeutics market growth is driven by increasing internet access globally in developed as well as developing countries. For instance, according to statistics of Our World in Data, in 2000, 7% of the Asian population had access to the internet, while just 3% of the African region was online. By 2016, the population share with internet access increased significantly, with 91% of the population in South Korea and Japan having internet access and 97% of the population in Denmark and Norway online. After six years, in 2022, major regions of Africa witnessed 81% of the population share gain internet access.

Government initiatives and incentives in order to digitalize the whole ecosystem are anticipated to boost the digital therapeutics market during the forecast years. Increased government funding in the healthcare sector and the introduction of schemes for the digitalization of the healthcare sector are expected to fuel the digital therapeutics market during the study time. For instance, in August 2023, the government of India introduced the Digital Health Incentive Scheme (DHIS) under the Ayushman Bharat Digital Mission (ABDM) to encourage the adoption of digital health, laboratories, and health tech companies. In the digital health incentive scheme, new health tech startups will be offered incentives up to 4 crore INR.

Employers and patients are the major consumers of digital therapeutic services. Major companies have started adding therapies as services in their employee packages, providing lifestyle management, depression, and hypertension-related services. Patients with chronic diseases, such as diabetes and cardiovascular diseases, can use the services for day-to-day consultation.

Digital Therapeutics Market Report Highlights

By revenue model analysis, the subscription segment is anticipated to experience substantial growth in the global market. This growth is attributed to major advantages that are associated with the subscription-based revenue model.

By end users analysis, the employers segment is anticipated to dominate the market from 2024 to 2032 due to major companies globally having started including digital therapeutics packages in their services.

In 2023, North America dominated the digital therapeutics market due to the large share of the population having internet access and increasing digitalization.

The digital therapeutics market in India is projected for substantial growth due to the regulatory support and initiatives for the digitalization of the healthcare sector.

The key market players are Proteus Digital Health, Inc.; Fitbit, Inc.; Pear Therapeutics, Inc.; Kaia Health; Happify, Inc.; Medtronic Plc.; Omada Health, Inc.; Livongo Health, Inc.; Voluntis Inc.; Resmed, Inc.; Welldoc, Inc.; 2Morrow Inc.; Canary Health; and Mindable Health GmbH.

Polaris Market Research has segmented the digital therapeutics market report based on revenue model, application, end users, and region:

By Revenue Model Outlook (Revenue - USD billion, 2019-2032)

  • Subscription
  • Value-based
  • One Time Purchase

By Application Outlook (Revenue - USD billion, 2019-2032)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Lifestyle Management
  • Preventive Applications
  • Others

By End Users Outlook (Revenue - USD billion, 2019-2032)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

By Regional Outlook (Revenue - USD billion, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Digital Therapeutics Market Insights

  • 4.1. Digital Therapeutics Market - Market Snapshot
  • 4.2. Digital Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Service Oriented Software Are Driving Market Growth
      • 4.2.1.2. Increase in Daily Hours Spend on Internet is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Capital Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Digital Therapeutics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Digital Therapeutics Market, by Revenue Model

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • 5.3. Subscription
    • 5.3.1. Global Digital Therapeutics Market, by Subscription, by Region, 2019-2032 (USD billion)
  • 5.4. Value Based
    • 5.4.1. Global Digital Therapeutics Market, by Value Based, by Region, 2019-2032 (USD billion)
  • 5.5. One Time Purchase
    • 5.5.1. Global Digital Therapeutics Market, by One Time Purchase, by Region, 2019-2032 (USD billion)

6. Global Digital Therapeutics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • 6.3. Diabetes
    • 6.3.1. Global Digital Therapeutics Market, by Diabetes, by Region, 2019-2032 (USD billion)
  • 6.4. Obesity
    • 6.4.1. Global Digital Therapeutics Market, by Obesity, by Region, 2019-2032 (USD billion)
  • 6.5. CVD
    • 6.5.1. Global Digital Therapeutics Market, by CVD, by Region, 2019-2032 (USD billion)
  • 6.6. CNS Disease
    • 6.6.1. Global Digital Therapeutics Market, by CNS Disease, by Region, 2019-2032 (USD billion)
  • 6.7. Respiratory Disease
    • 6.7.1. Global Digital Therapeutics Market, by CVD, by Respiratory Disease, 2019-2032 (USD billion)
  • 6.8. Smoking Cessation
    • 6.8.1. Global Digital Therapeutics Market, by Smoking Cessation, by Region, 2019-2032 (USD billion)
  • 6.9. Lifestyle Management
    • 6.9.1. Global Digital Therapeutics Market, by Lifestyle Management, by Region, 2019-2032 (USD billion)
  • 6.10. Preventive Applications
    • 6.10.1. Global Digital Therapeutics Market, by Preventive Applications, by Region, 2019-2032 (USD billion)
  • 6.11. Others
    • 6.11.1. Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

7. Global Digital Therapeutics Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 7.3. Patients
    • 7.3.1. Global Digital Therapeutics Market, by Patients, by Region, 2019-2032 (USD billion)
      • 7.3.1.1.
  • 7.4. Providers
    • 7.4.1. Global Digital Therapeutics Market, by Providers, by Region, 2019-2032 (USD billion)
  • 7.5. Payers
    • 7.5.1. Global Digital Therapeutics Market, by Payers, by Region, 2019-2032 (USD billion)
  • 7.6. Employers

Global Digital Therapeutics Market, by Employers, by Region, 2019-2032 (USD billion)

  • 7.7. Others

Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

8. Global Digital Therapeutics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
  • 8.3. Digital Therapeutics Market - North America
    • 8.3.1. North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.3.2. North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.3.3. North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.3.4. Digital Therapeutics Market - U.S.
      • 8.3.4.1. U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.3.4.2. U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.3.4.3. U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.3.5. Digital Therapeutics Market - Canada
      • 8.3.5.1. Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.3.5.2. Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.3.5.3. Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.4. Digital Therapeutics Market - Europe
    • 8.4.1. Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.4.2. Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.4.3. Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.4. Digital Therapeutics Market - UK
      • 8.4.4.1. UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.4.2. UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.4.3. UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.5. Digital Therapeutics Market - France
      • 8.4.5.1. France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.5.2. France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.5.3. France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.6. Digital Therapeutics Market - Germany
      • 8.4.6.1. Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.6.2. Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.6.3. Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.7. Digital Therapeutics Market - Italy
      • 8.4.7.1. Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.7.2. Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.7.3. Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.8. Digital Therapeutics Market - Spain
      • 8.4.8.1. Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.8.2. Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.8.3. Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.9. Digital Therapeutics Market - Netherlands
      • 8.4.9.1. Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.9.2. Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.9.3. Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.10. Digital Therapeutics Market - Russia
      • 8.4.10.1. Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.10.2. Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.10.3. Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.11. Digital Therapeutics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.11.2. Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.11.3. Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.5. Digital Therapeutics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.5.2. Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.5.3. Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.4. Digital Therapeutics Market - China
      • 8.5.4.1. China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.4.2. China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.4.3. China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.5. Digital Therapeutics Market - India
      • 8.5.5.1. India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.5.2. India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.5.3. India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.6. Digital Therapeutics Market - Malaysia
      • 8.5.6.1. Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.6.2. Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.6.3. Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.7. Digital Therapeutics Market - Japan
      • 8.5.7.1. Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.7.2. Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.7.3. Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.8. Digital Therapeutics Market - Indonesia
      • 8.5.8.1. Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.8.2. Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.8.3. Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.9. Digital Therapeutics Market - South Korea
      • 8.5.9.1. South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.9.2. South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.9.3. South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.10. Digital Therapeutics Market - Australia
      • 8.5.10.1. Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.10.2. Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.10.3. Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.11. Digital Therapeutics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.6. Digital Therapeutics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.6.2. Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.6.3. Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.4. Digital Therapeutics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.4.2. Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.4.3. Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.5. Digital Therapeutics Market - UAE
      • 8.6.5.1. UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.5.2. UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.5.3. UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.6. Digital Therapeutics Market - Israel
      • 8.6.6.1. Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.6.2. Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.6.3. Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.7. Digital Therapeutics Market - South Africa
      • 8.6.7.1. South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.7.2. South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.7.3. South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.8. Digital Therapeutics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.7. Digital Therapeutics Market - Latin America
    • 8.7.1. Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.7.2. Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.7.3. Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.4. Digital Therapeutics Market - Mexico
      • 8.7.4.1. Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.4.2. Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.4.3. Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.5. Digital Therapeutics Market - Brazil
      • 8.7.5.1. Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.5.2. Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.5.3. Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.6. Digital Therapeutics Market - Argentina
      • 8.7.6.1. Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.6.2. Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.6.3. Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.7. Digital Therapeutics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.7.2. Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.7.3. Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Proteus Digital Health, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Fitbit Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Pear Therapeutics, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Kaia Health
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Happify, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Medtronic Plc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Omada Health, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Livongo Health, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Voluntis, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Resmed, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Welldoc, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. 2Morrow Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Canary Health
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Mindable Health GmbH.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables:

  • Table 1 Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 2 Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 3 Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 4 North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 5 North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 6 North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 7 U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 8 U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 9 U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 10 Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 11 Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 12 Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 13 Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 14 Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 15 Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 16 UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 17 UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 18 UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 19 France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 20 France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 21 France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 22 Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 23 Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 24 Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 25 Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 26 Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 27 Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 28 Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 29 Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 30 Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 31 Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 32 Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 33 Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 34 Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 35 Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 36 Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 37 Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 38 Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 39 Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 40 Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 41 Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 42 Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 43 China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 44 China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 45 China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 46 India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 47 India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 48 India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 49 Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 50 Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 51 Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 52 Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 53 Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 54 Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 55 Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 56 Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 57 Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 58 South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 59 South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 60 South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 61 Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 62 Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 63 Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 64 Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 65 Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 66 Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 67 Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 68 Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 69 Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 70 Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 71 Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 72 Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 73 UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 74 UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 75 UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 76 Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 77 Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 78 Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 79 South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 80 South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 81 South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 82 Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 83 Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 84 Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 85 Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 86 Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 87 Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 88 Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 89 Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 90 Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 91 Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 92 Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 93 Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 94 Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 95 Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 96 Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 97 Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 98 Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 99 Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

List of Figures:

  • Figure 1. Global Digital Therapeutics Market, 2019-2032 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Revenue Model
  • Figure 7. Global Digital Therapeutics Market, by Revenue Model, 2023 & 2032 (USD billion)
  • Figure 8. Market by Application
  • Figure 9. Global Digital Therapeutics Market, by Application, 2023 & 2032 (USD billion)
  • Figure 10. Market by End User
  • Figure 11. Global Digital Therapeutics Market, by End User, 2023 & 2032 (USD billion)
  • Figure 12. Global Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
  • Figure 13. Strategic Analysis - Global Digital Therapeutics Market